Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Yotebieng

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
BMJ Global Health|March 24, 2025
The long-term impact of the COVID-19 pandemic on tuberculosis care and infection control measures in anti-retroviral therapy (ART) clinics in low- and middle-income countries: a multiregional site survey in Asia and AfricaMarie Ballif, Nicolas Banholzer, Lisa Perrig, et al.
Environmental Health : a Global Access Science Source|January 17, 2024
Household air pollution and risk of pulmonary tuberculosis in HIV-Infected adultsPatrick D M C Katoto, Dieudonné Bihehe, Amanda Brand, et al.
Research Square|October 27, 2023
Household Air Pollution and Risk of Pulmonary Tuberculosis in HIV-Infected AdultsPatrick D M C Katoto, Dieudonné Bihehe, Amanda Brand, et al.
Journal of the International AIDS Society|July 9, 2024
Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based surveySerra Lem Asangbeh-Kerman, Maša Davidović, Katayoun Taghavi, et al.
The Lancet. Infectious Diseases|February 13, 2019
Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort studyKathrin Zürcher, Marie Ballif, Lukas Fenner, et al.
Journal of the International AIDS Society|July 18, 2022
Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan AfricaMatthew L Romo, Ellen Brazier, Dominique Mahambou-Nsondé, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIVGabriela Patten, Karen Malateste, Carolyn Bolton Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2020
Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical ImplicationsBertin C Bisimwa, Jean B Nachega, Robin M Warren, et al.
The Lancet. HIV|September 5, 2025
HIV-related mortality time trends among children and young adolescents on antiretroviral therapy by age, treatment duration, and region: a systematic review and meta-regression analysisJiawei He, Edmond Brewer, Amanda Novotney, et al.
The Journal of Infectious Diseases|December 23, 2025
Accuracy of the phenotypic 1G test to detect Mycobacterium tuberculosis and drug resistance from sputa in the US-Mexico borderMia Aguirre, Doris Ayala, Juan Ignacio Garcia, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
BMJ Global Health|March 24, 2025
The long-term impact of the COVID-19 pandemic on tuberculosis care and infection control measures in anti-retroviral therapy (ART) clinics in low- and middle-income countries: a multiregional site survey in Asia and AfricaMarie Ballif, Nicolas Banholzer, Lisa Perrig, et al.
Environmental Health : a Global Access Science Source|January 17, 2024
Household air pollution and risk of pulmonary tuberculosis in HIV-Infected adultsPatrick D M C Katoto, Dieudonné Bihehe, Amanda Brand, et al.
Research Square|October 27, 2023
Household Air Pollution and Risk of Pulmonary Tuberculosis in HIV-Infected AdultsPatrick D M C Katoto, Dieudonné Bihehe, Amanda Brand, et al.
Journal of the International AIDS Society|July 9, 2024
Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based surveySerra Lem Asangbeh-Kerman, Maša Davidović, Katayoun Taghavi, et al.
The Lancet. Infectious Diseases|February 13, 2019
Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort studyKathrin Zürcher, Marie Ballif, Lukas Fenner, et al.
Journal of the International AIDS Society|July 18, 2022
Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan AfricaMatthew L Romo, Ellen Brazier, Dominique Mahambou-Nsondé, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIVGabriela Patten, Karen Malateste, Carolyn Bolton Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2020
Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical ImplicationsBertin C Bisimwa, Jean B Nachega, Robin M Warren, et al.
The Lancet. HIV|September 5, 2025
HIV-related mortality time trends among children and young adolescents on antiretroviral therapy by age, treatment duration, and region: a systematic review and meta-regression analysisJiawei He, Edmond Brewer, Amanda Novotney, et al.
The Journal of Infectious Diseases|December 23, 2025
Accuracy of the phenotypic 1G test to detect Mycobacterium tuberculosis and drug resistance from sputa in the US-Mexico borderMia Aguirre, Doris Ayala, Juan Ignacio Garcia, et al.
Pageof 18